home / stock / vyne / vyne news


VYNE News and Press, VYNE Therapeutics Inc Com From 02/01/21

Stock Information

Company Name: VYNE Therapeutics Inc Com
Stock Symbol: VYNE
Market: NASDAQ
Website: vynetherapeutics.com

Menu

VYNE VYNE Quote VYNE Short VYNE News VYNE Articles VYNE Message Board
Get VYNE Alerts

News, Short Squeeze, Breakout and More Instantly...

VYNE - VYNE Therapeutics Announces FDA Approval of AMZEEQ® (Minocycline) Label Update

BRIDGEWATER, N.J., Feb. 01, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a specialty pharmaceutical company focused on developing and commercializing proprietary therapies to address unmet needs in dermatology, today a...

VYNE - VYNE Therapeutics closes capital raise of $50M

VYNE Therapeutics ([[VYNE]] +3.6%) has closed its previously announced registered direct offering of 21.1M shares at $2.37/share, with net proceeds of $46.7M that will be used for working capital and general corporate purposes.Also, the Company raised an additional $34.3M of net proceeds from...

VYNE - VYNE Therapeutics Announces Closing of $50 Million Registered Direct Offering of Common Stock and Provides Corporate Update

BRIDGEWATER, N.J., Jan. 29, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that it has closed its previously announced registered direct offering of an aggregate of 21,097,046 shares of common stock a...

VYNE - Can Vyne Therapeutics Stock Keep Soaring?

Shares of beaten-down biotech stock Vyne Therapeutics (NASDAQ: VYNE) jumped more than 30% higher on Jan. 25, 2021, in response to a relatively minor development for its new acne treatments. In a nutshell, the company executed a contract that could boost sales of its recently launche...

VYNE - EXPR, KRMD among premarket losers

Repro Med Systems (KRMD) -18% on preliminary FY20 results and CEO transition.Sanchez Midstream Partners (SNMP) -17%.Express (EXPR) -16% as Wedbush sees company 'hemorrhaging cash'.Lipocine (LPCN) -14% on launch of public offering.Midatech Pharma (MTP) -10%&#...

VYNE - VYNE Therapeutics Announces $50 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules

BRIDGEWATER, N.J., Jan. 26, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”),  today announced that it has entered into definitive agreements with institutional and accredited investors for the sale of an aggregate of ...

VYNE - ATOS, EXPR, SOL and UAVS among midday movers

Gainers: Aemetis (AMTX) +105%.Express (EXPR) +98%.MingZhu Logistics (YGMZ) +50%.TS Innovation Acquisitions (TSIA) +45%.IZEA Worldwide (IZEA) +43%.Orbital Energy (OEG) +36%.VYNE Therapeutics (VYNE) +35%.Accelerate Diagnostics (AXDX) +35%.Atossa Therapeutics (ATOS) +33%...

VYNE - VYNE Therapeutics, Evolus leads healthcare gainers; Neuronetics, Akerna among major losers

Gainers: VYNE Therapeutics (VYNE) +33%, Evolus (EOLS) +33%, Accelerate Diagnostics (AXDX) +32%, Atossa Therapeutics (ATOS) +29%, Bionano Genomics (BNGO) +27%.Losers: Neuronetics (STIM) -14%, Akerna (KERN) -10%, Precigen (PGEN) -9%,&#...

VYNE - BB, GME, AMC and AUPH among premarket gainers

Express (EXPR) +131%.TS Innovation Acquisitions (TSIA) +82% on merger agreement with Latch Inc..Aemetis (AMTX) +60%.Spartan Acquisition Corp. II (SPRQ) +51% on entering into business combination agreement with Sunlight.VYNE Therapeutics (VYNE) +40%.GameStop (GME) +43%.Aurinia Pharma...

VYNE - Top Biotech Penny Stocks To Buy Right Now? 4 Up Big In 2021

These Biotech Penny Stocks Have Already Made Big Waves In 2021 But Can That Continue? If there’s one sector that’s been bullish for both penny stocks and blue-chips alike in 2021, it’s been biotech. Last year, we saw these stocks surge thanks to the onset of the...

Previous 10 Next 10